Purchase Order 75N94020P00666
Award Date 8/25/20
Potential Completion Date 8/24/21
Potential Value $25K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Australia
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a definitive contract awarded by the National Institutes of Health (NIH) to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $38,945,214.78, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice to support research into various diseases and disorders, such as hemoglobin disorders, red blood cell development,...
- This federal contract award to Ozgene PTY LTD, an Australian company, is for the construction of a DIO2CRE knock-out animal model. The contract, valued at $47,850.00, was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the U.S. Department of Health and Human Services. The contract is a firm fixed-price Purchase Order with no set-aside designation. Ozgene PTY LTD, a for-profit limited liability company, is the prime contractor for this...
- This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to Ozgene Pty Ltd, an Australian company. The contract, valued at $67,700.00, is for the provision of genetically modified mice and rats to support biomedical research. The contract does not have a set-aside designation. Ozgene, the prime contractor, will provide gene targeting vectors, mouse backcrossing,...
- This federal contract award to Ozgene PTY LTD, an Australian company, is for the provision of genetically modified mice and related services to support biomedical research. The $2,024 firm fixed-price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. Ozgene, the prime contractor, will deliver gene targeting vectors, mouse backcrossing, and the creation...
- This federal contract award is between the National Institutes of Health (NIH) and Ozgene Pty Ltd, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $69,600.00, is for the delivery of "LIVE ANIMALS, NOT RAISED FOR FOOD" and was awarded on September 22, 2009 with an ultimate completion date of April 28, 2010. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. Ozgene Pty...
- This is a federal contract award to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $1,504.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The contract is for Ozgene to maintain a small colony of mice for a 12-week period, including mating wild-type and...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the National Institutes of Health (NIH), to the prime contractor Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The $56,300.00 firm fixed-price delivery order is for services including gene targeting vector design and creation, mouse embryonic stem cell generation, blastocyst injection,...
- This federal contract award, valued at $50,600.00, was issued by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to the prime contractor Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract is for the provision of live animals, not raised for food, and does not have a set-aside designation. Ozgene has previously received other federal contract awards...
- This federal contract award to Ozgene PTY LTD, an Australian company, is for the delivery of genetically modified mice and related services to support biomedical research at various institutes and centers within the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The specific services provided under this $5,970.00 firm fixed price delivery order contract include gene targeting vector design and creation, mouse embryonic stem cell generation, blastocyst...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Ozgene Pty Ltd, an Australian company that provides genetically modified mice and related services to support biomedical research. The $17,298.00 firm fixed-price delivery order is for additional breeding services for genetically modified knock-in and knock-out mice, which are used to study various diseases and disorders such as...